<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Autoimmunity Archives - Laboratory Notes</title>
	<atom:link href="https://www.laboratorynotes.com/tag/autoimmunity/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.laboratorynotes.com/tag/autoimmunity/</link>
	<description></description>
	<lastBuildDate>Sun, 23 Aug 2026 20:02:09 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1</generator>
	<item>
		<title>Cbl‑b</title>
		<link>https://www.laboratorynotes.com/cbl-b/</link>
					<comments>https://www.laboratorynotes.com/cbl-b/#respond</comments>
		
		<dc:creator><![CDATA[admin]]></dc:creator>
		<pubDate>Sun, 23 Aug 2026 20:02:09 +0000</pubDate>
				<category><![CDATA[Database]]></category>
		<category><![CDATA[Database: Gene/Protein]]></category>
		<category><![CDATA[Lab Notes: Cancer Biology]]></category>
		<category><![CDATA[Lab Notes: Cell Biology]]></category>
		<category><![CDATA[Autoimmunity]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[CBL family]]></category>
		<category><![CDATA[Cbl‑b]]></category>
		<category><![CDATA[Immune signalling]]></category>
		<category><![CDATA[RING ligases]]></category>
		<guid isPermaLink="false">https://www.laboratorynotes.com/?p=29820</guid>

					<description><![CDATA[<p>Cbl‑b is a single‑chain RING finger ubiquitin ligase that acts as a master regulator of immune activation. By ubiquitinating key signalling molecules in T‑cells, B‑cells and NK cells, Cbl‑b maintains immune tolerance and prevents hyperactivation. Loss of Cbl‑b leads to autoimmunity and enhanced anti‑tumour immunity, making it a critical player in immune homeostasis and a promising target in cancer immunotherapy.</p>
<p>The post <a href="https://www.laboratorynotes.com/cbl-b/">Cbl‑b</a> appeared first on <a href="https://www.laboratorynotes.com">Laboratory Notes</a>.</p>
]]></description>
		
					<wfw:commentRss>https://www.laboratorynotes.com/cbl-b/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
